{
    "clinical_study": {
        "@rank": "109459", 
        "brief_summary": {
            "textblock": "To evaluate the safety and efficacy of early treatment with zidovudine for preventing a\n      decline in CD4+ lymphocyte counts in patients with primary HIV infection. To determine the\n      natural history of virologic and immunologic changes in primary HIV infection.\n\n      Previous studies indicate that intervention with zidovudine during primary HIV infection\n      could reduce the initial viral burden and subsequent decline in immune functions, and could\n      prolong not only the time to development of AIDS but also the time to initiation of chronic\n      antiretroviral therapy."
        }, 
        "brief_title": "Pilot Study to Evaluate the Efficacy of Zidovudine in Preventing CD4+ Lymphocyte Decline in Patients With Primary HIV Infection. (One Treatment Arm Receives Placebo)", 
        "completion_date": {
            "#text": "June 2002", 
            "@type": "Actual"
        }, 
        "condition": "HIV Infections", 
        "condition_browse": {
            "mesh_term": [
                "HIV Infections", 
                "Acquired Immunodeficiency Syndrome"
            ]
        }, 
        "detailed_description": {
            "textblock": "Previous studies indicate that intervention with zidovudine during primary HIV infection\n      could reduce the initial viral burden and subsequent decline in immune functions, and could\n      prolong not only the time to development of AIDS but also the time to initiation of chronic\n      antiretroviral therapy.\n\n      Patients are randomized to receive either zidovudine or placebo daily for 24 weeks. Patients\n      are followed until development of an AIDS-related opportunistic infection or malignancy.\n      After week 24, patients meeting standard prescribing criteria may start FDA-approved\n      anti-HIV therapies. After study week 48, patients may co-enroll on another clinical trial to\n      receive experimental therapy."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria\n\n        Concurrent Medication:\n\n        Allowed:\n\n          -  Medications for nausea, vomiting, analgesia, or anxiety.\n\n        Patients must have:\n\n          -  Asymptomatic or symptomatic primary HIV infection, plus one of the following two\n             criteria:\n\n               1. p24 antigenemia documented within 1 month prior to study entry and either HIV\n                  enzyme immunoassay (IA) negative or HIV IA positive with Western blot\n                  negative/indeterminate, within 1 month prior to study entry.\n\n               2. Documented seroconversion within 1 month prior to study entry and Western blot\n                  negative/indeterminate.\n\n          -  Consent of parent or guardian if less than 18 years of age.\n\n        Exclusion Criteria\n\n        Co-existing Condition:\n\n        Patients with the following condition are excluded:\n\n          -  poor venous access.\n\n        Concurrent Medication:\n\n        Excluded:\n\n          -  Chronic steroid use.\n\n          -  Immunomodulators.\n\n          -  Myelosuppressive agents.\n\n          -  Other antiretroviral agents or experimental therapies (NOTE: FDA-approved therapies\n             permitted in patients who qualify after week 24; experimental therapies permitted\n             after study week 48)."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "13 Years"
        }, 
        "enrollment": "80", 
        "firstreceived_date": "November 2, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00000765", 
            "org_study_id": "DATRI 002", 
            "secondary_id": "11733"
        }, 
        "intervention": {
            "intervention_name": "Zidovudine", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Zidovudine"
        }, 
        "keyword": "Zidovudine", 
        "lastchanged_date": "March 15, 2012", 
        "link": {
            "description": "Click here for more information about Zidovudine", 
            "url": "http://www.aidsinfo.nih.gov/DrugsNew/DrugDetailNT.aspx?MenuItem=Drugs&Search=On&int_id=4"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90048"
                    }, 
                    "name": "Cedars Sinai Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Palo Alto", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "94304"
                    }, 
                    "name": "Palo Alto Veterans Administration Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Fort Lauderdale", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33316"
                    }, 
                    "name": "Broward Gen Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60612"
                    }, 
                    "name": "Univ of Illinois"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Baltimore", 
                        "country": "United States", 
                        "state": "Maryland", 
                        "zip": "212872080"
                    }, 
                    "name": "Johns Hopkins Univ School of Medicine"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10016"
                    }, 
                    "name": "Bellevue Hosp / New York Univ Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Providence", 
                        "country": "United States", 
                        "state": "Rhode Island", 
                        "zip": "02906"
                    }, 
                    "name": "Miriam Hosp / Brown Univ"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dallas", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "75235"
                    }, 
                    "name": "Univ of Texas Southwestern Med Ctr of Dallas"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Houston", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "77006"
                    }, 
                    "name": "Houston Clinical Research Network"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "Pilot Study to Evaluate the Efficacy of Zidovudine in Preventing CD4+ Lymphocyte Decline in Patients With Primary HIV Infection. (One Treatment Arm Receives Placebo)", 
        "overall_official": [
            {
                "last_name": "M Niu", 
                "role": "Study Chair"
            }, 
            {
                "last_name": "H Standiford", 
                "role": "Study Chair"
            }
        ], 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "N/A", 
        "reference": {
            "citation": "Holodniy M, Niu M, Bethel J, Standiford H, Schnittman S. A pilot study to evaluate the efficacy of zidovudine (ZDV) versus placebo in primary HIV infection (DATRI 002): a preliminary analysis. Int Conf AIDS. 1996 Jul 7-12;11(Program Supplement):26 (abstract no LBB6022)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00000765"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "National Institute of Allergy and Infectious Diseases (NIAID)", 
        "sponsors": {
            "collaborator": {
                "agency": "Glaxo Wellcome", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "National Institute of Allergy and Infectious Diseases (NIAID)", 
                "agency_class": "NIH"
            }
        }, 
        "study_design": "Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2012"
    }, 
    "geocoordinates": {
        "Bellevue Hosp / New York Univ Med Ctr": "40.714 -74.006", 
        "Broward Gen Med Ctr": "26.122 -80.143", 
        "Cedars Sinai Med Ctr": "34.052 -118.244", 
        "Houston Clinical Research Network": "29.76 -95.369", 
        "Johns Hopkins Univ School of Medicine": "39.29 -76.612", 
        "Miriam Hosp / Brown Univ": "41.824 -71.413", 
        "Palo Alto Veterans Administration Med Ctr": "37.442 -122.143", 
        "Univ of Illinois": "41.878 -87.63", 
        "Univ of Texas Southwestern Med Ctr of Dallas": "32.803 -96.77"
    }
}